| Category: | Medical & Pharma, Pharmaceuticals |
|---|---|
| Organizer: | Informa Markets |
| Exhibition center: | Tokyo Big Sight - International Exhibition Center |
Hotels search near to Tokyo Big Sight - International Exhibition Center
Overview interest facts - ICSE Japan 2023
ICSE Japan 2023 brings together Japanese and international outsourcing companies & acts as a platform to connect with the pharma industry. The ICSE 2023 exhibitors offer a wide variety of outsourcing services, including clinical trials, IT, research, biotechnological, logistical and analytical services.
Overview of exhibitors / visitors - ICSE Japan 2023
Contract research, biotrails, pharmacology, photobiology testing, pre-clinical, toxicology. Clinical trials phase I to IV, clinical research (field), drug metabolism, in-patient clinical research, patient safety monitoring, pharmacodynamics, pharmacoeconomics, pharmacogenetics, pharmacokinetics, statistical analysis, pharmacology, photobiology testing, pre-clinical, toxicology, analytical services, chemical synthesis / analysis, custom manufacturing, formulation development, immunochemistry, logistics and distribution, product characterization, recruitment / human resources, synthetic organic chemistry. Contract manufacturing, blending, filling, lyophilization, packaging, regulatory. Marketing services, medical devices, cleaning equipment, hygiene testing, production equipment, quality control, biotechnology
Recommended events
Recommended events
News
AstraZeneca adds to rare blood disease portfolio with world-first Voydeya approval in Japan
A month after Novartis made its entry into the paroxysmal nocturnal haemoglobinuria (PNH) field, AstraZeneca’s newest contender Voydeya bolsters the company’s presence...
22 January 2024New material improves treatment of complex bone infections
Researchers in Ireland have combined antimicrobial implants and gene therapies to develop a new surgical solution with the potential to improve the treatment of comple...
29 November 2023Sepsis - as common as cancer, as deadly as a heart attack
In 2016, the research team conducted an initial study in southern Sweden (Skåne) where they revealed that sepsis is much more common than previously believed.
04 September 2023FDA approves first oral treatment for postpartum depression
Following the approval, Biogen plans for the commercial launch Zurzuvae (zuranolone) in Q4 2023.
10 August 2023New blood test finds two thirds of cancers
A new multi-cancer early detection blood test could speed up diagnosis.
16 June 2023EU Proposes Drug Manufacturing Overhaul, Faces Pushback
The European Union on April 26 has released a draft of the probable and proposed revamp of its drug manufacturing laws
04 May 2023